PMC6458881_01
Recurrent lesion before ECT treatment.
CRIONM2019-2507642.001.jpg
PMC6458881_01_CRIONM2019-2507642.001.jpg
fig1
After a month from the surgery, in May 2015, a new nodule appeared in correspondence of the graft, suggesting a recurrence (Figure 1).
Eschar after ECT treatment.
CRIONM2019-2507642.002.jpg
PMC6458881_01_CRIONM2019-2507642.002.jpg
fig2
ECT treatment, the mass diminished in diameter and appeared completely necrotized (Figure 2). Eight weeks after treatment, all that remained was an eschar that detached, leaving an erythematous zone of reepithelialization (Figure 3).
Eschar detached.
CRIONM2019-2507642.003.jpg
PMC6458881_01_CRIONM2019-2507642.003.jpg
fig3
ECT treatment, the mass diminished in diameter and appeared completely necrotized (Figure 2). Eight weeks after treatment, all that remained was an eschar that detached, leaving an erythematous zone of reepithelialization (Figure 3).
Restitutio ad integrum.
CRIONM2019-2507642.004.jpg
PMC6458881_01_CRIONM2019-2507642.004.jpg
fig4
This area disappeared within three months, with a complete restitutio ad integrum (Figure 4).